Design of the INHIBIT Trial: Preventing Inhibitors by Avoiding ‘Danger’, Prolonging Half-Life and Promoting Tolerance
Expert Review of Hematology - United Kingdom
doi 10.1586/17474086.2014.963550
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 5, 2014
Authors
Publisher
Informa UK Limited